Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin as Adjuvant to Propofol in TBI Sedation
NCT04034771Phase 3Completed
- Sponsor
- Cairo University
- Start
- Jan 2018
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melatonin in traumatic brain injury (TBI), sponsored by Cairo University. Started Jan 2018; status: completed.
02
Drugs
melatonin
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT04034771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04034771.